Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 30, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2013View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4May 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 20, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-116

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information